Skip to main content
Tessa NewsLink
Paste a health news link, or browse
Latest checks

Source study found

Story checked

This Diet And Exercise Combination Put Early-Onset Diabetes Into Remission in Half of Participants : ScienceAlert (opens in a new tab)

sciencealert.com · 2026-10-16

Short answerEvidenceSource

Short answer

Needs review

Study found.

We found the study, but the claim check did not finish.

Share this check

Follow the evidence trail
1

The story

This Diet And Exercise Combination Put Early-Onset Diabetes Into Remission in Half of Participants : ScienceAlert

sciencealert.com · 2026-10-16

The story’s checkable claims.

Read the original story (opens in a new tab)
2

NewsLink checks it

We found the study behind this story.

We found the study, but couldn't compare the story to it: the study's evidence could not be profiled.

Open claim evidence
3

The source study

Low energy diet plus supervised exercise vs. usual care alone in people with early-onset type 2 diabetes (RESET for Remission): a randomised, open-label, blinded-endpoint efficacy trial

The Lancet Regional Health - Americas · 2026
Then inspect each claim

Evidence layer

Claim by claim

The source study was found, but the study's evidence could not be profiled, so these claims couldn't be checked.

Finally, the search trail

Method layer

NewsLink found the paper. Tessa takes you deeper.

NewsLink checks the story. Tessa is where you inspect the paper, authors, evidence, and research context.

Open the paper in Tessa

Low energy diet plus supervised exercise vs. usual care alone in people with early-onset type 2 diabetes (RESET for Remission): a randomised, open-label, blinded-endpoint efficacy trial

The Lancet Regional Health - Americas · 2026

Why this one

Near certain

NewsLink found the paper. Tessa is where you inspect it deeply.

Papers considered

The selected paper, plus nearby candidates.

Crossref, PubMed, Europe PMC · 16 candidate papers

Selected

Low energy diet plus supervised exercise vs. usual care alone in people with early-onset type 2 diabetes (RESET for Remission): a randomised, open-label, blinded-endpoint efficacy trial

The Lancet Regional Health - Americas · 2026 · Crossref

And 10 more candidates considered.